Target intelligence / Profile preview

Rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR)

Target
RICTOR
Molecular classification
Signaling adaptor protein, Component of mTOR complex 2, Other
01

Overview

Rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR) is an essential protein subunit of the mTOR complex 2 (mTORC2), distinct from mTORC1 by its resistance to inhibition by rapamycin. RICTOR acts as a scaffold, facilitating the assembly and stability of mTORC2, which includes mTOR, mSIN1, and other regulatory proteins. mTORC2, through RICTOR, phosphorylates and activates several AGC kinase family members—most notably AKT (protein kinase B), PKC isoforms, and SGK1—regulating a diverse spectrum of biological processes such as growth, cytoskeleton reorganization, metabolism, and survival. mTORC2/RICTOR signaling has been implicated in multiple disease contexts, chiefly cancer and metabolic disorders, due to its central role in AKT activation and glucose metabolism. RICTOR does not possess catalytic activity itself but is vital for mTORC2 integrity and substrate specificity[1][2][3][4][5].

Other names
RICTORRPTOR independent companion of MTOR complex 2Rapamycin-insensitive companion of mTORmKIAA1851
02

Mechanism of action

Inhibition or degradation of mTORC2 components, including RICTOR, blocks downstream AKT activation[1][3].

03

Biological functions

Regulation of cell growthRegulation of cell proliferationCytoskeleton organizationSignal transductionProtein phosphorylationMetabolism regulation
04

Disease associations

CancerDiabetesMetabolic disordersOther
05

Safety considerations

Systemic inhibition can disrupt critical growth and metabolic processes in normal tissues[4]Targeting mTORC2 may lead to metabolic dysregulation and affect insulin signaling[3][4]
06

Interacting drugs

Perifosine

1 more in the full profile.

07

Biomarkers

RICTOR expression or phosphorylation status may serve as a biomarker in certain cancers (e.g., glioma, hematologic malignancies)[3]

Beyond the preview

Go deeper on Rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call